Understanding the Pathophysiology of Spinocerebellar Ataxias through genetics, neurophysiology, structural and functional neuroimaging by Pal, Pramod Kumar
Understanding the Pathophysiology of Spinocerebellar 
Ataxias through genetics, neurophysiology, 
structural and functional neuroimaging
Over the past 10 years a large cohort of 656 index patients with clinically suspected 
degenerative ataxias were clinically evaluated under various research projects.  Of 
these, 625 index patients underwent genetic tests for the clinically suspected most 
probable diagnosis.  A diagnosis could be achieved in 218 patients (34.9%).  Among 
these 218 index patients, 82 each were SCA1 and SCA2, 32 were SCA3, 4 were 
SCA12, and 18 were Friedreich's Ataxia.  Thus among the Autosomal Dominant 
Ataxias (SCAs) there was equal prevalence of SCA1 and SCA2 (41% each) followed 
by SCA3 (16%) and SCA12 (2%).  This high prevalence of SCA1 is in contrast to the 
available National and International literature.  The rate of clinical disease 
progression, especially in SCA2, was dependent on the CAG repeat size, and may 
commence linearly from birth.
Apart from cerebellar involvement, a comprehensive evaluation of the neuroaxis in 
various subsets of this genetically proved cohort showed subclinical involvement of 
the cerebral cortex, central motor and sensory pathways, peripheral nervous system 
and autonomic nervous system.  Important findings include: (a) A mixed sensorimotor 
and pure sensory neuropathy was seen in all the three subtypes of SCAs, while pure 
motor neuropathy was uncommon; (b) There was reduced cortical excitability and 
prolonged central motor conduction time, most evident in SCA1 and least in SCA2; (c) 
Cardiac autonomic dysfunction, predominantly parasympathetic, was seen in SCA, 
and the severity correlated with the duration of illness in SCA1; (d) In SCA1 there was 
a global impairment of balance, with greater instability in anterior–posterior than 
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Spinocerebellar ataxias (SCA) are 
genetically mediated autosomal dominant 
neurodegenerative disorders.  The burden 
of SCAs in India is large and diverse 
ethnicity of Indian population has led to 
different types of SCAs in different parts 
of India.  Documentation of the 
geneotypic-phenotypic correlation and 
understanding the pathophysiology of 
SCAs are crucial in management of these 
patients. 
Though in the past 2 decades there 
has been significant understanding in the 
genetics of Hereditary Ataxias, in 
particular SCAs (autosomal dominant 
ataxias), it is disturbing that there are very 
few Indian Research Centres which are 
dedicated to research in the field of 
Hereditary Ataxias.  One of the primary 
reasons behind this is the lack of 
understanding of the pathophysiology and 
lack of any specific treatment for SCAs.
Twenty-five years back, when I 
joined the National Institute of Mental 
Health & Neurosciences (NIMHANS), as 
a student in DM Neurology, I developed 
interest in Neurodegenerative Disorders, 
especially the Ataxias.  Pursuing my 
dissertation in Cerebellar Ataxias, I 
systematically studied the clinical, 
neuropsychological, electrophysiologic 
and imaging aspects of patients with 
Friedreich 's  Ataxia ,  Early-onset  
Cerebellar Ataxia with Retained Tendon 
Reflexes and Olivopontocerebellar 
Atrophies, based on the classification 
prevalent at that time.  The results of this 
study have been published in several 
National and International journals (1-5).  
Over the next decade, rapid genetic 
discoveries in the field of Autosomal 
Dominant Ataxias, later designated as 
Spinocerebellar Ataxias (SCAs),  
mandated a new look at the Hereditary 
Ataxias in India along with genetic 
studies.
I was fortunate to get a second 
opportunity to pursue my research interest 
in Cerebellar Ataxias when I joined 
NIMHANS as a Faculty in the 
Department of Neurology in 2000.  In 
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medio–lateral directions;  (e) In all the three SCAs there was a significant loss of gray 
matter in both cerebellar hemispheres and vermis.  Vermian atrophy was more 
pronounced in SCA3, while SCA1 and SCA2 had significant white matter atrophy.  
Pontine white matter atrophy was more pronounced in SCA2; (f) Cerebellar activity 
was largely absent with additional activity in contralateral cortices and in thalami in 
patients with SCA1; increased thalamic function could be one of the causes for 
disinhibition of the motor cortex contributing to uncoordinated movements.
Studies on larger cohort of each subtype of SCAs to validate the above findings, 
follow-up studies to determine the rate and nature of progression of neurodegeneration 
and evaluation of pre-symptomatic genetically confirmed SCAs will help understand 
the pathophysiology of the SCAs.
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collaboration with Dr. Mitali Mukherjee 
of the Institute of Genomics and 
Integrative Biology (IGIB), New Delhi 
and Prof. Sanjeev Jain at Genetic 
Laboratory of NIMHANS, we started a 
prospective study (2003) on “Phenotypic-
genotypic correlation of Spinocerebellar 
Ataxias in Southern India”, funded by a 
research grant from Indian Council of 
Medical Research (ICMR), New Delhi. 
This was the beginning of a large ongoing 
prospective research study on Hereditary 
Ataxias.  In the next 10 years, two more 
research grants from ICMR and several 
dissertations of students pursuing DM in 
Neurology helped us in establishing a 
large cohort of patients with hereditary 
ataxias.
The objectives of our study was to 
(i) establish a clinical and genetic database 
of hereditary ataxias with emphasis on 
epidemiology  of hereditary ataxias in 
India, (ii) try to achieve phenotypic-
genotypic correlation, (iii) clinical, 
radiological, electrophysiological 
characterization of genetically proven 
patients with hereditary ataxias, (iv) 
comparison of genetically proven patients 
from Southern and Northern India.
The results of our research in 
ataxias have been published in 22 articles 
in various National and International 
journals in the past one decade. Clinical 
data is still being analyzed and several 
projects are ongoing.  A large section of 
the cohort of our patients still do not have a 
genetic diagnosis and future genetic 
studies are required to identify the 
uncommon and novel genes.  Various 
imaging and electrophysiological 
investigations have been done only in 
subsets of patients with genetically 
proven SCAs.  Presented below are the 
salient findings in genetically proven 
cohort of SCAs.
Methods :
Cohort :
Over the past 10 years a large 
cohort of 656 index patients with 
clinically suspected degenerative ataxias 
were clinically evaluated under various 
research projects supervised by me.  Most 
of the patients were examined by me.  The 
patients were mainly from Southern India 
(Karnataka, Andhra Pradesh, Tamil Nadu 
and Kerala) and a considerable number of 
patients were also present from other parts 
of India, especially West Bengal, Bihar, 
Jharkhand, Assam, Orissa, Maharashtra, 
etc.  Some patients were evaluated in their 
respective States by Neurologists, and we 
cannot be certain if they were genetically 
evaluated by their treating physicians.
Blood sample was taken after 
written informed consent from the 656 
index patients and ~367 relatives (total 
samples~1023) and genetic studies of 
were done initially at IGIB and later at 
NIMHANS initially for the clinically 
suspected types of ataxias (viz. SCA1, 
SCA2, SCA3 , SCA 12, and Friedreich's 
ataxia).  When negative, further genetic 
tests in some samples were done for other 
types of ataxias in India (SCA6, SCA7, 
SCA8 and DRPLA, episodic ataxias, etc.) 
at IGIB.  
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In addition, several research 
studies were performed in small cohorts of 
genetically positive patients, focused on 
comprehensive evaluation of the neuro-
axis, using: 
(A) Electrophysiology:
a. Nerve conduction studies
b. M u l t i m o d a l  E v o k e d  
Potentials (VEP, BAER, 
Median and Posterior Tibial 
SSEP)
c. Transc ran ia l  Magne t i c  
Stimulation
(B) Autonomic Function Tests
(C) Spirometry
(D) Balance Evaluation
(E) Neuroimaging:
a. Structural: Routine and 
voxel-based morphometric 
studies using 3-Tesla MRI
b. Functional  :  fMRI for 
correlating the functional 
correlates of incoordination?
Results : 
Epidemiology:
Of the 625 index patients, a 
genetic diagnosis could be achieved in 
218 patients (34.9%) and in the 
asymptomatic 330 relatives in whom 
genetic analysis was done, another 28 
patients (8.5%) were positive for one of 
the genes tested.  Among the 218 index 
patients, 82 each were SCA1 and SCA2, 
32 were SCA3, 4 were SCA12, and 18 
were Friedreich's Ataxia.  Thus among the 
Autosomal Dominant Ataxias (SCAs) 
there was equal prevalence of SCA1 and 
SCA2 (41% each) followed by SCA3 
(16%) and SCA12 (2%).  Thus in our 
cohort, mainly from Southern India, the 
prevalence of SCA1 was equal if not 
higher than SCA2, which is similar to that 
reported by a study from (Vellore) Tamil 
Nadu, but in marked contrast to studies 
from rest of India, where most have 
reported highest prevalence of SCA2 
(Delhi, Kolkata and Mumbai) and one 
study reporting highest prevalence of 
SCA3 (Kolkata).  In most studies outside 
India, the prevalence of SCA3 is reported 
to be higher than SCA1 and SCA2.  
However, this difference of prevalence of 
the SCA1, 2 and 3 in various studies 
within India, needs to be validated in 
larger cohorts.  Moreover, there is a 
possibility of the same subjects taking part 
in genetic studies in more than one centre, 
due to referral practices. 
The following is a summary of the 
Clinical and genetic profile of 126 
genetically positive patients of SCA1, 2 
and 3.  Part of these results have been 
published earlier (6).
The prevalence of SCA1 (40.5%) 
and SCA2 (39.7%) were almost equal, 
while SCA3 constituted the rest (19.8%).  
We found that patients of the three groups 
were comparable with regards to the mean 
age, mean age at onset of symptoms and 
duration of illness. All the three subtypes 
of SCAs presented with ataxia, dysarthria 
and incoordination of limbs. However, the 
severity of ataxia, as measured by the 
IARS scores was higher in SCA2 
compared to the other groups. 
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Age at presentation and gender 
distribution:
The mean age of the patients at the 
time of presentation was in the fourth 
decade in all three groups. The mean age 
of patients of SCA1 was 34.1±10.7 years 
(range: 13-59 years). The mean age of 
patients of SCA2 was 32.9±12.8 years 
(range: 7-70 years). The mean age of 
patients of SCA3 was 36.8±12.2 years 
(range: 8-55 years). There was no 
statistical significant difference between 
the three groups.
There was a male preponderance 
in all the three groups. There were 37 
males (72.5%) in SCA1, 39 (78%) in 
SCA2 and 13 (52%) in SCA3. There was 
no statistical significance in the gender 
distribution. 
Age of onset and duration of illness:
The mean age of onset of illness 
was 29.8±9.9 years (range: 10-54 years) in 
SCA1, 27.6±12.2 years (range: 3-65 
years) in SCA2 and 32.8±12.4 years 
(range: 4-53 years) in SCA3, which was 
not statistically significant.
The mean duration of illness was 
4.7 ±4.1 yrs in SCA1 (range: 0.3-20 
years), 5.3 ±4.3 years (range: 0.5-15 
years) in SCA2 and 4.1 ±2.8 years (range: 
0.5-10 years) in SCA3. The statistical 
analysis for age of onset of illness and 
duration of illness did not reach 
statistically significant difference. 
Family history:
There was a positive family 
history present in a total of 101 patients 
(80.2%). Out of these patients an 
au tosomal  dominant  pa t te rn  of  
inheritance could be discerned in 43 
patients (84.3%) of SCA1, 38 patients 
(76%) of SCA2 and 20 patients (80%) of 
SCA3. The rest of the patients with a 
positive family history had affected 
siblings but a history of affection of 
parents was not forthcoming and since the 
parents were not examined, the pattern of 
inheritance could not be determined. 
There were a total of 7 patients with 
negative family history (i.e. sporadic 
inheritance): 4 patients of SCA1 (7.8%), 
one patient of SCA2 (2%) and 2 patients 
of SCA3 (8%).
CAG Repeat length:
The CAG repeat lengths were 
available in 118 patients. The mean CAG 
repeat length was 29.43 ±2.18 (range of 
39-72) for SCA1, 22.24 ±1.07 (38-66) for 
SCA2 and 21.88 ±5.82 (43-79) for SCA3. 
Clinical Features:
1. Skeletal abnormalities were most 
commonly observed in SCA3(40%), 
followed by SCA2 (30%) and SCA1 
(21.6%).
2. All the three groups presented with 
unsteadiness of gait, dysarthria and 
incoordination of limbs as the 
commonest presenting symptoms.
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3. The mean International Ataxia 
Rating Scale (IARS) scores 
significantly differed among the 
three groups with SCA2 patients 
having the greatest severity [SCA1: 
32.3±13.7 (range: 8-63), SCA2: 
41.1±17.1 (range: 14-94) and SCA3: 
31.1±21.2 (range: 10-94)].
4. Cognitive disturbances were 
commonest  in SCA1(15.7%)  
followed by  SCA2 (6%) and SCA3 
(4%).
5. Slow saccades were commonest in 
SCA2 (88%) followed by SCA1 
(49%) and SCA3 (40%).  Nystagmus 
was more often observed in SCA3 
(80%) than in SCA1 (19.6%) and 
SCA2 (10%).
6. Spasticity was seen more often in 
SCA1 (29.4%) compared to SCA2 
(16%) and SCA3 (8%). However, 
hypotonia was more in SCA3 (36%), 
followed by SCA2 (34%) and SCA1 
(23.5%). 
7. Vibration sensation loss in the lower 
limbs was more commonly seen in 
SCA2 (20%) compared to SCA1 
(9.8%) and SCA3 (4%).
8. SCA1 had more hyperreflexia 
(58.8%) compared to SCA3 (52%) 
and SCA2 (14%), while  SCA2 had 
more of hyporeflexia (22%) 
compared to SCA1 (7.8%) and 
SCA3 (0%).
9. Extensor plantars were more 
commonly seen in SCA1 (52.9%) 
than in SCA3 (48%) and SCA2 
(32%).
10. Exptrapyramidal signs (EPS) (7, 8):
 We specifically analyzed the 
prevalence of EPS in 85 patients of 
the above cohort who had genetically 
confirmed SCA (SCA1 = 40, SCA2 = 
28, SCA3 = 17). Forty-one SCA 
patients (48.2%) had one or more 
types of EPS. The prevalence of EPS 
was 60.7% in SCA2, 52.9% in 
SCA3, and 37.5% in SCA1. Among 
the SCA2 patients, bradykinesia was 
most frequent (35.3%), followed by 
reduced facial expression, postural 
tremor and dystonia (29.4% each), 
rest tremor, titubation and rigidity 
(23.5% each), and lip/jaw tremor and 
chorea (11.8% each). In SCA3 the 
common EPS were bradykinesia 
(44.4%), staring look, postural 
tremor and dystonia (33.3% each), 
and reduced facial expression and 
rigidity (22.2% each). In SCA1, 
staring look was the most common 
(53.3%), followed by dystonia and 
bradykinesia (33.3% each), and 
postural tremor (26.7%). In all the 
three groups, there was no significant 
difference in the mean length of 
repeat of the abnormal allele between 
those with and without EPS. 
 
 In summary, bradykinesia, staring 
look, dystonia and postural tremor 
were the most frequent EPS 
observed in SCA.  In SCA1, these 
signs were seen more often in 
younger patients with early onset of 
symptoms.
145 Pramod Kumar Pal
Electrophysiology assessment of the 
peripheral and central motor and 
sensory pathways and structures:
(a)  Nerve conduction studies (9) :
Subclinical neuropathy is an 
important feature of spinocerebellar 
ataxias (SCA) but the true prevalence and 
electrophysiological characteristics in 
genetically proven patients of SCA 1, 2 
and 3 are largely unknown.  There are no 
large comparative studies among SCA1, 2 
and 3.
We prospectively compared the 
electrophysiological characteristics of 
neuropathy in 61 genetically confirmed 
cases of SCA (SCA1=28, SCA2=16 and 
SCA3=17) of the above cohort. Nerve 
conduction studies were performed in at 
least one sensory and one motor nerve, in 
right upper and lower limb using standard 
methods.
The mean age of patients and 
duration of illness were comparable 
among SCA groups; mean age (years): 
SCA1=34.1±12.7, SCA2=35.2±13.9 and 
SCA3=38.1±11.3; mean duration (years): 
SCA1=5.4, SCA2=6.1, and SCA3=4.4).  
Electrophysiological evidence of 
neuropathy was highest in SCA1 (96.4%), 
followed by SCA3 (94.1%) and SCA2 
(87.5%).  A mixed sensorimotor  
neuropathy was commonly observed in all 
t h e  s u b g r o u p s  ( S C A 1 = 7 8 . 6 % ,  
SCA2=50%, and SCA3=41.2%). Pure 
sensory neuropathy was most common in 
SCA3 (55.9%), followed by 31.3% in 
SCA2 and 17.9% in SCA1. Pure motor 
neuropathy was uncommon (6.3% in 
SCA2 and none in SCA1 and SCA3).
In summary, electrophysiological 
evidence of mixed sensorimotor and pure 
sensory neuropathy was seen in all the 
three subtypes of SCAs, while pure motor 
neuropathy is distinctly uncommon.  
Electrophysiological profile revealed 
h ighe r  abnorma l i t i e s  o f  mo to r  
conductions in both upper and lower limbs 
in SCA1 compared to the other two 
groups.   However,  the sensory 
conductions were more often abnormal in 
SCA2 and SCA1 in upper limbs and were 
almost comparable among the three 
groups in the lower limbs. The 
abnormalities of sensory nerves were 
more often observed in the upper limbs 
than in the lower limbs in all the three 
groups of SCAs, which points in favour of 
a non-length dependent sensory 
neuropathy in the SCAs.
(b)  Evoked potentials (10) :
Multimodal evoked potential 
studies are useful tools to determine the 
integrity of the central pathways, viz. 
visual, auditory and somatosensory.  
Clinical sensory symptoms are usually 
uncommon in SCAs, and therefore it is of 
utmost importance to determine 
subclinical involvement, especially in the 
early disease, to devise symptomatic 
therapeutic strategies, prognostication, 
and determine the efficacy of therapeutic 
interventions.  In SCAs, BAER was the 
most common abnormality among the 
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evoked potentials studied. SCA1 patients 
had more often abnormalities of VEP 
abnormality, SCA2 of BAER, and SCA3 
of median SSEP. 
In this study, we evaluated 43 
genetically proven SCA (SCA1= 19, 
SCA2=13, SCA3=11) with median 
somatosensory evoked potent ia l  
(mSSEP), visual evoked potential (VEP) 
and brainstem auditory evoked response 
(BAER) by standard procedures and 
compared with normative laboratory data.  
The aims were to determine the pattern 
and prevalence of abnormalities of EPs in 
each type of SCA and additionally 
evaluate if EP can be used to differentiate 
between them.
The most common abnormality 
was of BAER (86.1%) followed by VEP 
(34.9%) and mSSEP (30.2%). The degree 
of abnormality in VEP, mSSEP, BAER 
among patients with SCA1 was 42.1%, 
41.2 % and 73.3% respectively; among 
patients with SCA2 was 38.5%, 27.3% 
and 100% respectively; among patients 
with SCA 3 was 18.2%, 37.5% and 88.9% 
respectively. The differences between the 
subgroups of SCAs were not statistically 
significant. 
I n  s u m m a r y,  s u b c l i n i c a l  
involvement of the visual, auditory and 
somatosensory pathways was very 
common in SCAs. BAER was the most 
frequent abnormality in SCA types 1, 2 
and 3; abnormalities of mSSEP were 
comparable in the three SCAs whereas 
abnormality of VEP was less often noted 
in SCA3. 
(c)  T r a n s c r a n i a l  M a g n e t i c  
Stimulation (11) :
T r a n s c r a n i a l  M a g n e t i c  
Stimulation (TMS) is a useful non-
invasive tool to state the changes of 
cortical excitability changes in neuro-
psychiatric disorders.  The prevalence of 
changes in the cortical excitability and 
central motor conduction time (CMCT) in 
these disorders is largely unknown, and 
there are few studies which have 
compared these findings in the subtypes of 
SCA. 
The objectives of this study were 
to measure the cortical resting motor 
threshold (RMT) and CMCT using 
transcranial magnetic stimulation in 
patients with SCA1, SCA2, and SCA3. 
Thirty-two  genetically confirmed 
patients with SCA (SCA1=15, SCA2 =11, 
SCA3 = 6) were studied.  TMS was 
performed using a figure-of-eight coil 
attached to Magstim 200 stimulator. 
Motor evoked potentials were recorded 
from first dorsal interosseous at rest. RMT 
was determined using standard techniques 
and the CMCT by 'F' wave method.  
Comparison was made with data from 32 
healthy controls.
We found that compared to 
controls, the patients with SCA had 
significantly higher mean RMT as well as 
CMCT (RMT: 49.9±9.1 vs. 41.5± 6.6, p < 
0.0001; CMCT: 7.7±2.3 ms vs. 4.8±0.6 
ms; p < 0.0001).  When compared 
separately with the controls, while all the 
three subtypes of SCAs had significantly 
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prolonged CMCT, only SCA1 and SCA3, 
but not SCA2 had significantly greater 
RMT.  RMT and CMCT between patients 
with SCA2 and SCA3, and between SCA1 
and SCA3 did not differ significantly, 
while SCA1 had significantly higher 
RMT and CMCT than SCA2.
In summary, we found that 
patients with SCA have reduced cortical 
excitability and prolonged central motor 
conduction time, which was most evident 
in SCA1 and least in SCA2.
Autonomic functions (12):
Progressive cerebellar ataxia 
because of neurodegeneration is seen in 
autosomal dominant spinocerebellar 
ataxias (SCA), autosomal recessive 
ataxias, idiopathic late onset ataxias and 
multiple system atrophy of cerebellar type 
(MSA-C). In these disorders, apart from 
progressive gait and limb ataxia, there are 
varying degrees of abnormalities of ocular 
m o v e m e n t s ,  p y r a m i d a l  s i g n s ,  
propioceptive loss and autonomic 
dysfunction. Autonomic dysfunction in 
these progressive ataxias result from 
degeneration of central autonomic 
neurons as well as degeneration of rostral 
fastigial nucleus of cerebellum which 
actively participates in regulation of 
orthostatic homeostasis and other 
autonomic control mechanisms. While 
au tonomic  dys func t ion  i s  we l l  
documented in MSA-C, there is sparse 
information of its nature and prevalence in 
idiopathic late onset ataxia not fulfilling 
the criteria of MSA-C, and in SCAs apart 
from SCA3 ⁄Machado-Joseph disease 
(MJD). Among the various manifestations 
of autonomic dysfunction, cardiac 
autonomic dysfunction may be an 
important cause of morbidity and 
mortality and therefore merits early 
detection.
Keeping the above in mind, we did 
a comparative evaluation of cardiac 
dysautonomia in SCA and idiopathic 
sporadic ataxias (IA) not fulfilling the 
criteria of multiple system atrophy. 
Cardiac autonomic functions were 
evaluated in 14 SCA (SCA1 = 6, SCA2 = 5 
and SCA3 = 3) and 10 IA patients, 
comparable for age, age at onset, duration 
and severity of illness. The results were 
categorized as early, definitive, or severe 
autonomic involvement (EI, DI and SI 
respectively) based on the degree of 
abnormalities on tests of parasympathetic 
and sympathetic pathways. 
It was found that cardiac 
autonomic dysfunction was present in all 
(EI = 25.0%, DI = 41.7% and SI = 33.3%), 
parasympathetic dysfunction being an 
early feature. SI was most often present in 
SCA3 (100%), followed by those with 
SCA1 (66.7%), and SCA2 (20%) and 
none in IA (12). 
Therefore, cardiac dysautonomia 
was common in both SCA and IA, 
although the severity was greater in SCA. 
Among SCAs, the severity was greatest in 
SCA3, followed by SCA2 and least in 
SCA1.
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In another study (13) we studied 
the cardiac autonomic function by using 
analysis of heart rate variability in 22 
genotypically proven SCA patients 
(SCA1 = 11, SCA2 = 6 and SCA3 = 5) and 
compared with that of age- and gender- 
matched controls. Consecutive RR 
intervals were analyzed for time- and 
frequency- domain parameters.  
There was a reduction in the 
standard deviation of RR interval 
(RR_SD) in 72.7% of SCA patients. There 
w a s  a  r e d u c t i o n  i n  b o t h  t h e  
parasympathetic and sympathetic 
parameters in SCA without any change in 
the ratio of low- to high- frequency power. 
In SCA1, there was a significant negative 
correlation between RR_SD and duration 
of illness but not with the CAG repeat 
lengths of the abnormal allele. Small 
sample size of SCA2 and SCA3 precluded 
similar comparison. 
This study showed that cardiac 
autonomic dysfunction, predominantly 
parasympathetic, was seen in SCA, and 
the severity correlated with the duration of 
illness in SCA1.
The above information is of 
p a r a m o u n t  i m p o r t a n c e  f o r  
prognostication of SCAs and also 
cautions when using drugs in SCA which 
can cause autonomic dysfunction, 
especially cardiac, even in those patients 
who do not have clinical autonomic 
dysfunction.  The SCA3 patients are more 
likely to have the maximum severity of 
cardiac dysautonomia.
Spirometry:
The presence of cerebellar and 
brain stem atrophy has been reported in 
SCA, and imaging and pathological 
studies suggest degeneration of certain 
neurons and their pathways in the 
olivopontocerebellar system. Because of 
the proximity of the respiratory neurons 
with these areas, it is logical to expect 
dysfunction in the respiratory control 
mechanisms which may manifest as 
altered pulmonary function tests (PFTs). 
Similar pulmonary dysfunction has been 
studied in other degenerative neurological 
disorders such as amyotrophic lateral 
sclerosis (ALS), Parkinson's disease, 
ataxia telangiectasia and multiple system 
atrophy.  However, to the best of our 
knowledge, there are no large studies 
which have specifically evaluated 
pulmonary dysfunction in SCA.  
Therefore we undertook this study to look 
for evidence of pulmonary dysfunction in 
SCA and if present, determine its nature, 
extent and correlation, if any, with the 
clinical characteristics such as functional 
disability, duration of illness and type of 
genetic abnormality. 
Thirty patients (F:M = 7:23;age: 
35.0±11.3 years; SCA1=13, SCA2=9 and 
SCA3= 8) without clinical manifestations 
of respiratory dysfunction and 30 controls 
underwent pulmonary function tests (14).   
It was observed that there was subclinical 
restrictive type of pulmonary dysfunction 
in all the SCA subtypes, though SCA1 and 
SCA2 patients appeared to be more 
affected than SCA3.  In addition, there 
was a possible presence of upper airway 
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o b s t r u c t i o n .   T h e r e f o r e  c h e s t  
physiotherapy and breathing exercises 
should be introduced early in management 
of SCA.  Patients with early morning 
fatigue, reduced cognition should be 
carefully evaluated for sleep apnea as a 
result of upper airway obstruction.
Balance assessment:
Evalua t ion  of  ba lance  in  
degenerative ataxias is often clinical and 
subject to bias. Very few studies have 
attempted to determine the characteristics 
of abnormal balance in SCA, quantify the 
degree of impairment, and compare with 
balance characteristics of healthy 
subjects. Such information is essential to 
plan balance rehabilitation strategies, 
determine the effectiveness of therapeutic 
interventions and to prognosticate ataxic 
disorders. 
We undertook this study to 
determine the prevalence, nature, and 
degree of balance impairment in patients 
of genetically proven SCA1, using Biodex 
balance measurement system (15). The 
findings were compared with age and 
gender matched controls. We also 
attempted to correlate the balance indices 
with age, body weight, and clinical 
severity of symptoms, age of onset, 
duration of symptoms and the size of CAG 
repeat.
The subjects were 20 patients 
(males: 14, females: 6) with genetically 
positive SCA1 and 20 age and gender 
matched healthy subjects. Ataxia was 
rated using the International Cooperative 
Ataxia Rating Scale (ICARS). Balance 
was assessed by dynamic posturography 
(Biodex, USA) which included: (a) ability 
to control balance in all directions (overall 
balance index, OBI), front to back 
(anterior–posterior index, API) and side-
to-side (medio–lateral index, MLI); and 
(b) the limits of stability (LOS) in all 
directions. Balance index was considered 
abnormal if the actual value exceeded the 
predictive value. 
Impaired balance was found in 
80% of patients (all indices in 35%, OBI + 
API in 25%, only OBI in 15%, and OBI + 
MLI in 5%). Compared to controls, SCA1 
patients had significantly higher balance 
indices and lower LOS scores. Unlike in 
controls, the mean value of API was 
significantly higher than MLI in SCA1. 
LOS was found to the best predictor of 
balance abnormality. In patients, all 
balance indices had significant positive 
correlations with ICARS, static score of 
ICARS, body weight, severity and 
duration of illness, but not with the CAG 
repeat length.
In summary, patients with SCA1 
had global impairment of balance, with 
greater instability in anterior–posterior 
than medio–lateral directions. Apart from 
severity and duration of illness, body 
weight was detriment to maintenance of 
balance in SCA1. This information may 
be  use fu l  in  p lann ing  ba lance  
rehabilitation in SCA.
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Neuroimaging:
Routine imaging:
On MRI study, SCA2 patients had 
more severe cerebellar atrophy, hot-cross 
bun sign and inferior pontine atrophy 
compared to other two groups. SCA3 
patients had milder cerebellar atrophy 
compared to the other two groups. 
Voxel-based Morphometry :
T h e r e  a r e  n o  u n i q u e  
distinguishing features on routine 
neuroimaging to distinguish between 
SCA1, 2 and 3. Therefore we undertook a 
r e c e n t l y  i n t r o d u c e d  a d v a n c e d   
neuroimaging technique-Voxel-based 
morphometry (VBM), to study the pattern 
and degree of brain atrophy in  patients 
with genetically proved SCA.  VBM 
provides an automated unbiased analysis 
of structural MRI scans and gives a 
comprehensive assessment of anatomical 
differences throughout the brain.  Our 
aims were to characterize the patterns of 
atrophy in SCA1, SCA2 and SCA3, 
determine if any unique pattern of atrophy 
can differentiate these three most 
commonly prevalent SCAs and finally to 
ascertain if a relationship exists between 
the morphometric measures and the CAG 
repeat lengths and other attributes of the 
disease.
We studied 31 genetically 
confirmed patients suffering from SCA 
(SCA1=12, SCA2= 9, and SCA3=10) 
(16). High resolution T1-weighted 3-
Dimensional MRI Images were analyzed 
using the optimized VBM procedure.  We 
found a significant loss of gray matter in 
both cerebellar hemispheres and vermis in 
all the three SCAs. SCA3 patients had 
more pronounced vermin atrophy, 
whereas SCA1 and SCA2 patients had 
significant white matter atrophy. Pontine 
white matter atrophy was more 
pronounced in SCA2.
Interestingly, only in SCA1 we 
could find a strong positive correlation 
with the severity of ataxia (as measured by 
International Cooperative Ataxia Rating 
Scale) and the degree of gray matter 
atrophy in cerebellar hemispheres. 
However, in all the 3 subtypes of SCAs, 
the duration of symptoms and lengths of 
CAG repeats had no correlation with the 
degree of atrophy.
In summary, this unique study 
showed that different subtypes of SCAs 
may have morphometric differences in the 
ce rebe l lum,  b ra ins t em and  the  
supratentorial structures.  It is required to 
serially follow up these patients with 
VBM to see if the rate of progression of 
disease correlate with rate of brain 
atrophy.
Functional imaging :
Functional magnetic resonance 
imaging (fMRI) of the entire brain was 
used to study the neural (blood 
oxygenation level dependent) correlates 
of motor coordination of both hands in 
adult right-handed volunteers and 7 
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patients with SCA1 (17).  The subjects 
performed 5 sets of alternate pronation 
and supination tasks using  either hand in a 
prescribed sequence as the active phase 
followed by a period of rest.  The motor 
network consisting of sensorimotor 
cortex, supplementary motor area, 
cingulate motor area, putamina and 
cerebellum, was identified during the task 
in healthy volunteers. However, in SCA1 
group the cerebellar activity was largely 
absent.  In addition there were activities in 
contralateral cortices and in thalami. This 
apparent decoupling of sensorimotor 
cortical and cerebellar areas during 
coordinated movement in patients with 
SCA1, suggests malfunctioning of the 
corticocerebellar loops. Therefore the 
basis of incoordination in SCA1 was the 
dysfunctional activity of the striatal and 
the cerebellar structures resulting in 
abnormal motor network coordination. 
(Jayakumar et al, 2008).
Therapeutics:
The treatment options for 
improving the balance in degenerative 
cerebellar ataxias are very few. The 
primary management for SCAs is gait and 
balance therapy.  However Ayurvedic 
texts have described diverse treatment 
regimens for this disease.   Therefore we 
undertook an open labeled pilot study 
using Ayurvedic therapy to determine if 
this therapy can improve balance indices 
measured by dynamic posturography 
(Biodex Balance System, USA).
Ten patients with progressive 
degenerative cerebellar ataxia (3 women, 
7 men; SCA1=2, SCA2=2, SCA3=1; rest 
of the patients were negative for SCA1,2 
and 3) participated in this study (18).  The 
patients were treated over a period of one 
month.  Treatment consisted of Shirobasti 
(therapeutic retention of medicament over 
the scalp) in male patients and Shirodhara 
(pouring of a steady stream of 
medicament on the forehead) in female 
patients with Dhanvantaram tailam 
(medicated oil) for 45 minutes daily, 
followed by Abhyanga (methodical 
massage) with Dhanvantaram tailam and 
Bhashpa sweda (steam bath), for 14 days. 
In addition, the treatment also consisted 
Abhyantara aushadha (oral medicines) of 
Maharasnadi kashayam 15 ml thrice daily, 
Dhanvantaram capsules 101 two capsules 
thrice daily, and Ashwagandha tablet 500 
mg one tablet thrice daily, for one month. 
The patients were assessed on the Biodex 
balance system before and after the 
treatment. 
All patients tolerated the treatment 
well without any adverse events and 
reported subjective improvement in 
walking. There was a statistically 
significant improvement in the overall 
and anteroposterior balance indices of 
dynamic stability.  Thus, over the short 
period of the present study, Ayurvedic 
therapy was found to be safe and, showed 
improvement in the balance in patients 
with progressive degenerative cerebellar 
ataxia.  However, further randomized 
placebo-control double blind studies are 
needed to validate the results.
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Disease Progression:
Neurodegenerative disorders 
show a variable rate of disease 
progression depending on the nature of 
underlying genetic defect, sites of nervous 
system involvement, and age of onset.  In 
addition, for the same disease there may 
be difference in the phenotypic 
expression, severity and progression of 
illness among different individuals, even 
belonging to the same family. It is 
important to know the rate of disease 
progression to prognosticate the illness, 
and to monitor the efficacy of therapeutic 
measures for symptomatic treatment or 
disease modification. 
We attempted to determine 
whether there is any correlation between 
the clinical rate of disease progression at 
presentation and the CAG repeat size in 71 
patients with SCA (SCA1=31, SCA2=25, 
and SCA3=15) (19).  The severity of 
ataxia  was measured using the 
International Cooperative Ataxia Rating 
Scale (IARS) in all the patients and the 
rate of disease progression at presentation 
was measured by the age adjusted IARS 
(IARS/Age). For each SCA, correlations 
of age at onset of symptoms, raw scores of 
IARS, age adjusted IARS and duration 
adjusted IARS (IARS/Duration) with the 
CAG repeat size were determined.
In this cohort, the number of CAG 
repeats of the abnormal allele ranged from 
42 to 67 in SCA1, 38 to 66 in SCA2, and 
69 to 79 in SCA3. In all the three types of 
SCAs, there were significant inverse 
correlations of AAO with CAG repeat size 
(SCA1: r = −0.9, p<0.0001; SCA2: r = 
−0.7, p<0.0001; SCA3:−0.8, p=0.0003) 
and significant positive correlations of 
IARS/Age with CAG repeat size (SCA1: r 
= 0.6, p=0.0015; SCA2: r = 0.9, p<0.0001; 
SCA3: r = 0.7, p=0.0057). However, the 
raw IARS scores and the duration adjusted 
IARS scores  d id  no t  cor re la te  
significantly with the CAG repeat sizes.
Therefore, our data suggested that 
the rate of clinical disease progression at 
presentation, especially in SCA2, is 
dependent on the CAG repeat size, and 
may commence linearly from birth.
Advanced genetics in Ataxias: 
Comparison between North and South 
Indian populations:
Ancestral origin of the hereditary 
ataxias and comparison between cohorts 
from North and South India has been done 
in collaboration with IGIB, New Delhi.  
Details of the findings in SCA (20) and 
Friedreich's ataxia (21) have been 
published.
We are currently following up this 
cohort of ataxias at NIMHANS and also 
studying other changes of sleep pattern in 
ataxias.  A patient with sleep benefit in 
episodic ataxia has been reported by us 
(22).
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